General Archive
-
News releasesLifeArc contributes to revitalisation of groundbreaking science education centre for children and young people
Centre of the Cell is the first informal science education centre in the world to be located within working biomedical…
-
News releasesDr Melanie Lee CBE steps down as CEO of LifeArc
Dr. Melanie Lee has notified the Board of her decision to step down as Chief Executive Officer, effective 30 September…
-
Articles
2022 wrapped – our highlights from a pivotal year
We’ve seen some exciting scientific progress, forged new partnerships and launched some new landmark initiatives.
-
News releases
LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2
LONDON, UK, 17 May 2022 — LifeArc today announced that RQ Biotechnology Ltd (RQ Bio), a company it co-founded, has…
-
News releasesLifeArc bolsters scientific leadership by appointing new Chief Scientific Officer
Welcome to Dr Dave Powell, who has joined LifeArc as our first Chief Scientific Officer (CSO). Dave is an experienced scientist and leader, with exceptional translational…
-
News releasesLifeArc unveils new strategy and £1.3 billion spend to drive life-changing science
Aims to transform the way diseases such as motor neurone disease are prevented, identified and treated.
-
News releasesMRCT and Chinese National Centre collaborate on malaria
MRCT’s Drug Discovery Group has developed a drug screening assay for a potential Malaria drug target called PfSub-1, a subtilisin-like…
-
News releasesMRC to receive over USD200m
The Medical Research Council is to receive over US$200m as part of one of the biggest deals to come out…